With COPD, you can be at risk for serious complications that not only put your health in jeopardy, but also could be fatal. We'll share tips for preventing them.

Learn about COPD medications, including bronchodilators, steroids, and combination treatments. Understand how they work, their side effects, and ways to manage COPD effectively.

GSK has said new data leads it to believe Nucala will be "highly competitive" with rival biologic Dupixent in COPD if it gets approved by the FDA.

Zileuton is an option in treating mild-to-moderate asthma but has been used anecdotally to treat severe asthma based on bronchoscopic evidence of increased neutrophilic inflammation in severe ...

Rationale Heart failure (HF) management in chronic obstructive pulmonary disease (COPD) is often delayed or suboptimal. Objectives To examine the effect of HF and HF medication use on ...

Vitamin D supplementation did not have any statistically significant effect on the proportion of participants experiencing at least one moderate or severe COPD exacerbation; the time to first moderate ...

Smoking status had a significant interaction with most exacerbation outcomes in participants with a BEC off ICS of at least 200 cells/µL and BEC change less than 0 cells/µL. For those with BEC change ...

Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.

Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year ...

Patients with bronchiectasis face heightened risks of severe exacerbation and mortality after COVID-19 recovery, especially following severe cases.

Commentary on an important review and meta analysis to evaluate the effectiveness of emergency treatments for COPD.

Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients with moderate to very severe COPD characterized by an eosinophilic phenotype, according to ...